
BOLD Stock Forecast & Price Target
BOLD Analyst Ratings
Based on 15 analyst ratings
Hold
Strong Buy 20%
Buy 33%
Hold 33%
Sell 7%
Strong Sell 7%
BOLD has been analyzed by 15 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.
This aggregate rating is based on analysts' research of Boundless Bio Inc and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Boundless Bio Inc and is not a guaranteed prediction by Public.com or investment advice.
BOLD Analyst Forecast & Price Prediction
Get the latest BOLD stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in BOLD
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Boundless Bio Inc (BOLD) Forecast
Analysts have given BOLD a Hold based on their latest research and market trends.
According to 15 analysts, BOLD has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $33.07, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $33.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.